Customers Bancorp (CUBI) 26.12 $CUBI Jay Sidhu Wins

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Customers Bancorp (CUBI) 26.12 $CUBI

Jay Sidhu Wins Ernst & Young Fintech Entrepreneur Of The Year Award in Greater Philadelphia
Marketwire Canada - Fri Jun 10, 10:45AM CDT
Chairman and CEO of BankMobile and Customers Bank Honored for Innovation at June 9, 2016 Awards Ceremony
CUBI: 26.12 (+0.84)

Customers Bancorp, Inc. to Host Analyst Day at The Harvard Club on June 23, 2016
Marketwire Canada - Thu Jun 09, 10:00AM CDT
Executives to Discuss Future of BankMobile, America's First and Only No-Fee Digital Bank
CUBI: 26.12 (+0.84)

BankMobile's Chairman and CEO Receives Honorary Degree From Albright College
Marketwire Canada - Mon May 23, 10:02AM CDT
Jay Sidhu Honored for His Business Accomplishments and Community Service During College's 157th Commencement
CUBI: 26.12 (+0.84)

Atlantic Coast Financial Corporation Re-Elects Dave Bhasin and John J. Dolan
BusinessWire - Mon May 23, 9:35AM CDT
Atlantic Coast Financial Corporation (the Company) (NASDAQ: ACFC), the holding company for Atlantic Coast Bank (the Bank), today reported on its 2016 annual meeting of stockholders. In formal business conducted at the meeting, stockholders re-elected two directors to three-year terms that expire with the 2019 annual meeting: Dave Bhasin, Chief Executive Officer of D.B. Concepts, Inc. and affiliated companies, which operates franchised restaurants throughout eastern Pennsylvania, and John J. Dolan, Chairman of the Board for the Company and the Bank and a Managing Member of Dolan Finance, LLC, which serves as general partner for Dolan Real Estate Finance, LP, a newly formed private investment fund that deals in financing short-term commercial real estate transactions.
CUBI: 26.12 (+0.84), ACFC: 6.20 (+0.15)

Customers Bancorp, Inc. Corrects Quarterly Cash Dividend on Its Series E Preferred Stock
Marketwire Canada - Wed May 18, 3:34PM CDT
WYOMISSING, PA--(Marketwired - May 18, 2016) - Customers Bancorp, Inc. issued a correction to the Press Release dated May 10, 2016. The quarterly cash dividend amount on the Perpetual Preferred Stock, Series E, was inadvertently reported incorrectly. The corrected dividend amount is stated below. The dividend amounts previously reported in the May 10, 2016 press release for the Perpetual Preferred Stock, Series C and Perpetual Preferred Stock, Series D were reported correctly.
CUBI: 26.12 (+0.84)

Customers Bancorp, Inc. to Hold Analyst Day In New York on June 23, 2016
Marketwire Canada - Tue May 17, 11:59AM CDT
Company Intends to Discuss in Some Details Its Plan for BankMobile
CUBI: 26.12 (+0.84)

Customers Bancorp Announces It Will Be Added to the S&P SmallCap 600(R) Index
Marketwire Canada - Wed May 11, 1:03PM CDT
WYOMISSING, PA --(Marketwired - May 11, 2016) - Customers Bancorp, Inc. (NYSE: CUBI), the parent company for Customers Bank, today announced it will be added to the S&P SmallCap 600® Index, as of the close of trade on Friday, May 13, 2016.
CUBI: 26.12 (+0.84)

CORRECTION - Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series C, Series D and Series E Preferred Stock
Marketwired - Tue May 10, 7:34PM CDT
WYOMISSING, PA--(Marketwired - May 10, 2016) - In the news release, "Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series C, Series D and Series E Preferred Stock" issued earlier today by Customers Bancorp, Inc., we are advised by the company that the second sentence of the fourth paragraph should read "Customers Bank is a community-based, full-service bank with assets of approximately $9.0 billion as of March 31, 2016." rather than "Customers Bank is a community-based, full-service bank with assets of approximately $9.0 billion as of December 31, 2015." as originally issued. Complete corrected text follows.
CUBI: 26.12 (+0.84)

Customers Bancorp, Inc. Declares Quarterly Cash Dividend on Its Series C, Series D and Series E Preferred Stock
Marketwired - Tue May 10, 9:26AM CDT
WYOMISSING, PA--(Marketwired - May 10, 2016) - Customers Bancorp, Inc. announced that the Board of Directors has declared a quarterly cash dividend on its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series C (NYSE: CUBIPrC) of $0.4375 per share. The dividend is payable on June 15, 2016 to shareholders of record on May 31, 2016.
CUBI: 26.12 (+0.84)

Customers Bancorp and Ingevity Set to Join the S&P SmallCap 600
PR Newswire - Mon May 09, 6:00PM CDT
S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600:
SPGI: 110.00 (+2.87), CUBI: 26.12 (+0.84), WRK: 41.34 (+0.88), REXX: 0.81 (+0.01), NGVT: 34.66 (+0.19), CKP: 10.14 (unch)

Is Customers Bancorp (CUBI) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 7:09AM CDT
Customers Bancorp is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
CUBI: 26.12 (+0.84)

Customers Bancorp Announces Pricing of Public Offering of Preferred Stock
Marketwire Canada - Thu Apr 21, 5:21PM CDT
Customers Bancorp, Inc. (the "Company" (NYSE: CUBI), the parent company for Customers Bank, today announced the pricing of its public offering of 2,000,000 shares of the Company's Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series E (the "Series E Preferred Stock" at a price of $25.00 per share. The underwriters have been granted a 30-day option to purchase up to an additional 300,000 shares of Series E Preferred Stock from the Company at the public offering price less the underwriting discount. Dividends on the Series E Preferred Stock will accrue and be payable quarterly in arrears, at a fixed rate per annum equal to 6.45% from the original issue date to, but excluding, June 15, 2021, and thereafter at a floating rate per annum equal to three-month LIBOR on the related dividend determination date plus a spread of 5.14% per annum.
CUBI: 26.12 (+0.84)

Customers Bancorp Reports First Quarter 2016 Net Income up 17.6% Over Prior Year
Marketwired - Thu Apr 14, 3:15PM CDT
Customers Bancorp, Inc. (NYSE: CUBI), the parent company of Customers Bank (collectively "Customers", reported net income to common shareholders of $16.4 million for the first quarter of 2016 ("Q1 2016" compared to net income to common shareholders of $14.0 million for the first quarter of 2015 ("Q1 2015", an increase of $2.5 million, or 17.6%. Fully diluted earnings per share for Q1 2016 was $0.57 compared to $0.49 fully diluted earnings per share for Q1 2015, an increase of $0.08 per share, or 16.3%. Average fully diluted shares for Q1 2016 were 28.8 million compared to average fully diluted shares of 28.3 million for Q1 2015.
CUBI: 26.12 (+0.84)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading